Chinese biopharmaceutical firm Zai Lab Ltd. has secured over US$100 million in series B financing led by Advantech Capital Partners Ltd., an investment fund established by the co-founder of secretive princeling private equity firm New Horizon Capital, says an announcement. Healthcare-dedicated investment firm OrbiMed, existing investors Qiming Ventures Partners, Sequoia Capital China and TF Capital […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.